Last $88.91 USD
Change Today -3.10 / -3.37%
Volume 2.5M
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey M. Leiden M.D., Ph.D.

Chairman, Chief Executive Officer and President, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 126 board members in 5 different organizations across 8 different industries.

See Board Relationships
58$13,126,474
As of Fiscal Year 2013

Background*

Dr. Jeffrey M. Leiden, M.D., Ph.D. has been Chief Executive Officer and President of Vertex Pharmaceuticals Inc. since February 1, 2012. Dr. Leiden has been Managing Director of Clarus Ventures since 2007. Dr. Leiden joined Clarus Ventures in November 1, 2006 as a Partner. Dr. Leiden has more than 20 years of experience in the biomedical and pharmaceutical sectors. He served as President and Chief Operating Officer at Abbott Laboratories Pharmaceutical Products Group ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Director
Member of Executive Committee of Board of Trustees
Trustee
Trustee
Former Chairman
Former Chairman
1999-2006
Former President of Pharmaceutical Products Group, Chief Operating Officer of Pharmaceutical Products Group and Director
2007-N/A
Former Independent Director and Member of Research & Development Committee
2007-2012
Former Vice Chairman, Chairman of Science & Technology Committee, Member of Nomination Committee and Member of Remuneration Committee
2008-Present
Director
2008-N/A
Former Chairman, Member of Audit Committee and Member of Compensation Committee
2009-Present
Chairman, Chief Executive Officer and President

Education*

MA
Harvard University
PhD
The University of Chicago
Bachelor's Degree
The University of Chicago
BA
The University of Chicago
MD
The University of Chicago

Other Affiliations*

Annual Compensation*

Salary$1,038,462
Total Annual Compensation$1,038,462

Stock Options*

Restricted Stock Awards$1,773,963
All Other Compensation$12,675
Exercisable Options379,799
Exercisable Options Value$14,592,694
Unexercisable Options553,836
Unexercisable Options Value$16,423,130
Total Value of Options$31,015,824
Total Number of Options933,635

Total Compensation*

Total Annual Cash Compensation$3,823,137
Total Short Term Compensation$1,038,462
Other Long Term Compensation$1,786,638
Total Calculated Compensation$13,126,474
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $88.91 USD -3.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.